RE:Compelling despite Headwinds Well if it goes to $3/sh or cash valuation then it is time for me to double down. I did not think that chance would come. The market is getting past stupid now. Beyond team has had a tough break with the FDA. I wonder if their China presence played a factor. The market deserves some clarity on the issue that the FDA has so hopefully we get that soon. China progression is still in play and the milestone payments are worth more than the market cap at the moment. This valuation appears to be a bad joke but fortunately no cash neeeds to be raised so bring it on. GLTA.